for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Celldex Therapeutics, Inc.

CLDX.OQ

Latest Trade

12.94USD

Change

0.83(+6.85%)

Volume

925,825

Today's Range

12.11

 - 

13.10

52 Week Range

1.51

 - 

13.90

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Celldex Therapeutics Q2 Loss Per Share $0.50

Aug 6 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::Q2 REVENUE $0.2 MILLION VERSUS $0.7 MILLION.CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2020 RESULTS.Q2 LOSS PER SHARE $0.50.TOTAL REVENUE WAS $0.2 MILLION IN Q2 OF 2020 VERSUS $0.7 MILLION IN Q2 2019.

Adage Capital Partners L.P. Reports 5.01% Passive Stake In Celldex Technologies As Of July 14, 2020 - SEC Filing

July 24 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::ADAGE CAPITAL PARTNERS L.P. REPORTS 5.01% PASSIVE STAKE IN CELLDEX TECHNOLOGIES AS OF JULY 14, 2020 - SEC FILING.

Ikarian Capital Reports 7.1% Passive Stake In Celldex Therapeutics

June 18 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::IKARIAN CAPITAL LLC REPORTS 7.1% PASSIVE STAKE IN CELLDEX THERAPEUTICS INC AS OF JUNE 10 - SEC FILING.

Celldex Therapeutics Says Offering Of 13.4 Mln Common Shares Priced At $9.75 per Share

June 16 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::CELLDEX THERAPEUTICS ANNOUNCES PRICING OF $130.4 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS OFFERING OF 13.4 MILLION COMMON SHARES PRICED AT $9.75PER SHARE.

Celldex Therapeutics Announces Proposed Public Offering Of Common Stock

June 15 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::CELLDEX THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.

Celldex Therapeutics Q4 Loss Per Share $0.64

Celldex Therapeutics Inc <CLDX.O>::CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND YEAR END 2019 RESULTS.Q4 LOSS PER SHARE $0.64.Q4 REVENUE $900,000 VERSUS $9.5 MILLION.CELLDEX THERAPEUTICS - BELIEVES CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AT DEC 31, 2019 SUFFICIENT TO FUND PLANNED OPERATIONS INTO Q1 2021.

Celldex Therapeutics To Receive $1.7 Mln Milestone Payment From Rockefeller Uni

March 3 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::CELLDEX THERAPEUTICS ANNOUNCES $1.7 MILLION MILESTONE PAYMENT FROM ROCKEFELLER UNIVERSITY RELATED TO COLLABORATION ON HIV ANTIBODY PROGRAM.

Celldex Therapeutics Files For Mixed Shelf Of Upto $150 Million

Dec 6 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::CELLDEX THERAPEUTICS FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING.

Celldex Provides Corporate Update And Reports Third Quarter 2019 Results

Nov 12 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER 2019 RESULTS.Q3 LOSS PER SHARE $0.75.Q3 REVENUE $500,000 VERSUS $7.8 MILLION.

Celldex Therapeutics Says Q2 Loss Per Share $0.84

Aug 7 (Reuters) - Celldex Therapeutics Inc <CLDX.O>::CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2019 RESULTS.Q2 LOSS PER SHARE $0.84.Q2 REVENUE $700,000 VERSUS $6.8 MILLION.CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF JUNE 30, 2019 WERE $81.3 MILLION.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up